Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Type 1 Diabetes Prediction and Prevention (DIPP) Study

NCT03269084 is registered in ClinicalTrials.gov with Riitta Veijola as lead sponsor.

NCT NCT03269084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03269084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Type 1 Diabetes Prediction and Prevention (DIPP) Study
Lead sponsor
Riitta Veijola
Phase
Observational
Overall status
Unknown status
Start date
November 7, 1994
Completion date
December 31, 2024
Enrollment
17,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus